anti-mrsa activity

Show results for

Unknown (379)
Proteomics (18)
Transcriptomics (11)
Genomics (10)
Metabolomics (8)

Organisms

Staphylococcus aureus (12)
Allexis (8)
Arabidopsis thaliana (8)
Homo sapiens (8)
Listeria monocytogenes (8)
Mus musculus (8)
Rattus norvegicus (8)
Saccharomyces cerevisiae (8)
Schizosaccharomyces pombe (8)
Shigella (8)
Shigella flexneri (8)
Archaea (7)
Bacteria (7)
Betaherpesvirinae (7)
Borrelia (7)
Clostridium perfringens (7)
Eukaryota (7)
Staphylococcus aureus subsp. aureus NCTC 8325 (2)
Mycobacterium tuberculosis (1)
Staphylococcus aureus subsp. aureus COL (1)
Staphylococcus aureus subsp. aureus MRSA252 (1)
Staphylococcus aureus subsp. aureus MSSA476 (1)
Staphylococcus aureus subsp. aureus MW2 (1)
Staphylococcus aureus subsp. aureus Mu50 (1)
Staphylococcus aureus subsp. aureus N315 (1)
Staphylococcus aureus subsp. aureus USA300 (1)
Staphylococcus aureus subsp. aureus USA300_FPR3757 (1)
Eremophila rugosa (1)
Candida albicans (1)
Chaetomium globosum (1)

Organisms

Staphylococcus aureus (4)
Staphylococcus aureus subsp. aureus USA300_FPR3757 (1)

Repository

ENA (10)
pride (8)
biostudies-arrayexpress (7)
MetaboLights (7)
iProX (6)
geo (4)
MassIVE (4)
GNPS (1)

Tissue

Cell suspension culture (1)
Epithelial cell (1)
Kidney (1)
Skin (1)

Disease

Disease by infectious agent (1)
Disease free (1)

Technology Type

Mass Spectrometry (8)
Shotgun proteomics (7)
Mass spectrometry (5)
Affinity purification coupled with mass spectrometry proteomics (3)
Mass spectrometry assay (2)
SRM/MRM (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse-phase (4)
Liquid Chromatography MS - positive - reverse-phase (4)
Q Exactive HF-X (2)
MicrOTOF II (1)
Q Exactive (1)
Q Exactive Orbitrap HF (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (7)
2011 (4)
2021 (4)
2025 (4)
2022 (3)
2023 (3)
2010 (2)
2024 (2)
2013 (1)
2012 (1)
2009 (1)
2018 (1)
2020 (1)
2019 (1)
2017 (1)

CHEBI ID

CHEBI:16932 (1)
CHEBI:138525 (1)
CHEBI:73318 (1)
CHEBI:112 (1)
CHEBI:7034 (1)
CHEBI:5588 (1)
CHEBI:16022 (1)
CHEBI:6945 (1)
CHEBI:6277 (1)
CHEBI:34984 (1)
CHEBI:8984 (1)
CHEBI:10088 (1)
CHEBI:2984 (1)
CHEBI:88955 (1)
CHEBI:89478 (1)
CHEBI:29458 (1)
CHEBI:73644 (1)
CHEBI:88610 (1)
CHEBI:73341 (1)
CHEBI:5955 (1)
CHEBI:35050 (1)
CHEBI:73979 (1)
CHEBI:73386 (1)
CHEBI:34407 (1)
CHEBI:34019 (1)
CHEBI:5637 (1)
CHEBI:29466 (1)
CHEBI:35028 (1)
CHEBI:9627 (1)
CHEBI:4607 (1)

Metabolite Name

Riboflavin (4)
LPC(O-18:1) (3)
LPC(18:0/0:0) (3)
Spermidine (3)
Guanosine (3)
Methionine (3)
Betaine (3)
Adenosine (3)
1-Pentadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine (2)
Purmorphamine (2)
Leu-Lys (2)
Phospho-L-arginine (2)
Carnitine C20:2 (2)
Imperialine (2)
Carnitine C13:0 (2)
Bufogenin (2)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine (2)
C22 Sphingomyelin (2)
C22 Sulfatide (2)
Bakkenolide A (2)
Methyl caffeate (2)
PC(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (2)
Glycyl-L-tyrosine (2)
2-(n-Heptanoyl)thiophene (2)
1-Tetracosanoyl-sn-glycero-3-phosphocholine (2)
1,2-Docosahexanoyl-sn-glycero-3-phosphocholine (2)
LPC(0:0/22:4) (2)
1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine (2)
Carnitine C17:0 (2)
Carnitine C16:2 (2)

First Public Date

2026 (4)
2014 (2)
2025 (1)
2024 (1)
2022 (1)
2019 (1)

Classification

bacteria (5)

Study type

Transcription profiling by array (5)
Unknown experiment type (1)
RNA-seq of coding RNA (1)

Release Date

2025 (56)
2023 (49)
2022 (49)
2021 (42)
2024 (33)
2019 (33)
2020 (29)
2018 (22)
2017 (12)
2016 (12)
2026 (11)
2015 (9)
2011 (7)
2014 (7)
2012 (6)
2013 (5)
2010 (2)
2009 (2)

Lab affiliation

School of Pharmacy, Walailak University, Nakhon Si Thammarat, 80161, Thailand (2)
Center for Integrated Protein Science Munich (CIPSM) at the Department of Chemistry, Technische Universität München, Lichtenbergstraße 4, 85747 Garching b. München (1)
Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching b. München 85747, Germany; Chair of Organic Chemistry II, Technische Universität München, Garching b. München 85747, Germany (1)
Centre for Bioinnovation, University of the Sunshine Coast (1)
Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST) (1)
School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX (1)
Technische Universität München Department of Chemistry Lehrstuhl Organische Chemie II Lichtenbergstr. 4 85747 Garching (bei München) (1)

Previous page
1 / 43
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 43
Next page

Sort by:

Relevance

Page size

Deciphering the Anti-Biofilm Mechanism of Anthraquinone-2-Carboxylic Acid Against MRSA by Comprehensive Multi-Omics Analysis

Background: Methicillin-resistant Staphylococcus aureus (MRSA) biofilms exhibit high levels of drug resistance and cause nosocomial infections in humans, thus posing a sustainable global health threat. This underscores the critical need to develop novel antibiofilm therapeutics with high efficacy...

2025-09-18 | MTBLS13012 | MetaboLights

Discovery of isokurarinone as an ATCase-Engaging Lead with potent activity against methicillin-resistant Staphylococcus aureus

The global proliferation of methicillin-resistant Staphylococcus aureus (MRSA) persists as a significant contributor to challenging infections, highlighting the urgent necessity for therapies that utilize novel mechanisms. Aspartate transcarbamoylase (ATCase), which catalyzes the initial committe...

2026-01-14 | MTBLS13673 | MetaboLights

Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis Improved the Anti-MRSA Activity of Brevibacillus sp. SPR20

Brevibacillus sp. SPR20 produced potentially antibacterial substances against MRSA. The synthe-sis of these substances is controlled by their biosynthetic gene clusters. Several mutagenesis methods are used to overcome the restriction of gene regulations when genetic information is ab-sent. Atmosphe...

ORGANISM(S): Brevibacillus sp.

2023-08-31 | PXD043954 | Pride

The anti-MRSA compound KCR inhibits protein synthesis in Staphylococcus aureus

S aureus was treated in triplicate with 3-O-alpha-L-(2",3"-di-p-coumaroyl)rhamnoside (KCR), oxacillin or vehicle and quantitative proteomic analysis was carried out using isobaric tags and mass spectrometry. 1190 proteins were identified and 552 were affected by KCR (q<0.01). Ontology analysis ide...

ORGANISM(S): Staphylococcus Aureus (ncbitaxon:1280)

MSV000084282 | MassIVE

Novel anti-virulence compounds disrupt exotoxin expression in MRSA

Hemolysins are lytic exotoxins expressed in most strains of S. aureus, but hemolytic activity varies between strains. We have previously reported several novel anti-virulence compounds that disrupt the S. aureus transcriptome, including hemolysin gene expression. This report delves further into our ...

ORGANISM(S): Staphylococcus aureus

2024-05-15 | GSE267020 | GEO

Novel anti-virulence compounds disrupt exotoxin expression in MRSA

PRJNA1109356 | ENA

Discovery of Brominated Alboflavusins With Anti-MRSA Activities.

Not available

S-EPMC7920986 | biostudies-literature

Novel Tricyclic Flavonoids as Promising Anti-MRSA Agents.

Not available

S-EPMC11510641 | biostudies-literature

Synergistic anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and absolute stereochemistry of 7,8-dideoxygriseorhodin C.

Not available